Sign in
4

Changes in Ownership

Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-25-010181

Options or other derivatives

  • Chief Financial Officer acquired 145,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Shawah Robert G. Chief Financial Officer 2025-02-05 Grant or award · Stock Option +145,500 145,500 D
Loading xslF345X05/tm255798-3_4seq1.xml…